Stay updated on MBG453 Combination with Azacitidine Clinical Trial
Sign up to get notified when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.

Latest updates to the MBG453 Combination with Azacitidine Clinical Trial page
- CheckyesterdayChange DetectedThe study has been terminated due to a lack of statistical significance in its primary endpoint of overall survival, despite some positive trends. Additionally, the date of the study's termination has been updated to March 25, 2025.SummaryDifference5%
- Check8 days agoChange DetectedThe date for an event has been updated from December 12, 2024, to March 17, 2025.SummaryDifference1.0%
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check44 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check51 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
Stay in the know with updates to MBG453 Combination with Azacitidine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MBG453 Combination with Azacitidine Clinical Trial page.